No insider purchase over the last 90 days. The latest, by Qian Fenglei, was filed 20 Jul 2026.
WellCell Holdings Co., Ltd., classified in the Media sector, is a listed company. Its insiders report their share dealings to HKEX. Over the twelve months to 25 October 2026, 5 filings were filed, from 2 insiders.
Both sides are active: 1 purchase worth €21.2M and 3 sales worth €55.3M, from 1 insider and 2 insiders respectively. Sales outweigh purchases by €34.1M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The buyers include 1 senior executive. Biggest ticket of the year: €21.9M, sold by 林启豪 and made public on 16 June 2026.
The most recent open-market purchase was published on 20 July 2026, 97 days ago. Typically, a trade is published a median of 1 day after it takes place. The shorter that gap, the sooner other investors can see what insiders have done. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification.
Compared with its exchange (1,315 companies, median 4 filings), a count of 5 filings is above the norm. Our records for WellCell Holdings Co., Ltd. go back to 2024, with 2 purchases and 9 sales on the open market in total.
Elsewhere in the same sector, our signals recently picked up insider purchases at ZEAL Network SE and CTS Eventim AG & Co. KGaA. Source: insider filings from HKEX. Past trades are no guide to future returns.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
FY ended December 2025 · cache
25 of 25 declarations
WellCell Holdings Co., Ltd. is a company focused on developing health and wellness solutions. It emphasizes innovation in the health technology sector.
Purchases our model currently ranks for the recommendations list.
All recommendations